Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of three insulin glargine dose-titration protocols in hospitalized patients with type 2 diabetes
ChiCTR-TRC-12001916Phase 4Completed
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Start
- Feb 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of insulin glargine in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Second Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Fasting blood glucose. Started Feb 2011; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-12001916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12001916.